1. Prognostic Significance of Systemic Inflammatory Response in Patients with Synchronous and Metachronous Metastatic Renal Cell Carcinoma Receiving First-Line Tyrosine Kinase Inhibitors
    Joongwon Choi et al, 2019, The Korean Journal of Urological Oncology CrossRef